Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Researchers from the University of Copenhagen have discovered a new weight loss drug target that works without causing nausea ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

With new weight-loss drugs hailed as ‘miracle’ medicines, Harriet Symonds explores whether their increasing popularity should ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Researchers said the analysis lays bare a ‘decades-long-failure’ to tackle the overweight and obesity epidemic ...

The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September and, according to ...

Nearly three-quarters of U.S. adults are overweight or obese, according to a sweeping new study. The findings have ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...